Table 4.
Percentage of individuals reporting limitations or problems (i.e., a level 2 or level 3 response) in EQ-5D-3L domains in patients with VVS, POTS, and OH compared to population/regional norms.
| Mobility | Self-care | Usual activities | Pain/discomfort | Anxiety/depression | |
|---|---|---|---|---|---|
| VVS (n = 136) (32) | 25.9* | 9.0* | 37.2* | 49.2 | 43.4* |
| POTS (n = 44) (49) | 60*† | 35*†‡ | 95*†‡ | 81*† | 56* |
| OH (n = 117) (54) | 53.8*† | 16.2* | 28.2* | 67.5*† | 45.3* |
| Population normative data | |||||
| United States (n = 38,678) (59) | 18.5 | 3.7 | 17.9 | 48.3 | 23.2 |
*
Significantly different when compared with normative data from the United States, at the 0.05 level of significance.
†
Significantly different to the VVS group, at the 0.05 level of significance.
‡
Significantly different to the OH group, at the 0.05 level of significance.